{
  "title": "The immune signature of palmoplantar pustulosis",
  "identifier": {
    "identifier": "http://www.immport.org/immport-open/public/study/study/displayStudyDetail/SDY667",
    "identifierSource": "http://www.immport.org"
  },
  "producedBy": {  "name": "The immune signature of palmoplantar pustulosis",
  "performedBy": [
    {
      "firstName": "Gerlinde",
      "lastName": "Obermoser",
      "email": "gerlinde.obermoser@baylorhealth.edu",
      "affiliations": [
          {
             "name": "Baylor Institute for Immunology research"
          }
      ],
      "roles": [
          {
             "value": "Principal Investigator"
          }
      ]
    }
  ],
  "studyGroups": [
        {
          "name": "HIPC-PSOR-PPP",
          "size": 50
        }
  ],
  
  "usesReagent": [
        {
          "name": "GX-BeadChip HT12v4"
        }
  ],
  
  "selectionCriteria": [
        {
          "category": "Inclusion",
          "values": [
              "Subjects are age 18 years or older, with a diagnosis of palmoplantar pustulosis (PPP)"
          ]
        },
        {
          "category": "Exclusion",
          "values": [
              "Are pregnant, nursing, or planning a pregnancy while enrolled in the study"
          ]
        }
  ],
  
  "types": [
      {
          "value": "Observational"
      }
  ]
  },
  "creators": [
    {
      "firstName": "Gerlinde",
      "lastName": "Obermoser",
      "email": "gerlinde.obermoser@baylorhealth.edu",
      "affiliations": [
          {
             "name": "Baylor Institute for Immunology research"
          }
      ],
      "roles": [
          {
             "value": "Principal Investigator"
          }
      ]
    },
    {
      "name": "Systems Analysis Vaccine Responses in Healthy and Hyporesponsive Humans",
      "extraProperties": [
        {
          "category": "Catgory",
          "values": [
            {
              "value": "DAIT"
            }
          ]
        },
        {
          "category": "External Id",
          "values": [
            {
              "value": "AI089987"
            }
          ]
        },
        {
          "category": "Description",
          "values": [
            {
              "value": "Our goal is to identify early biomarkers of effective antibody responses to flu vaccination. Four aims are proposed to meet this goal: Aim 1: To establish the baseline immune profiles in healthy subjects. Aim 2: To establish the immune profiles of Flu vaccination in healthy subjects. Aim 3: To identify the molecular signatures of DC subset(s) in response to Flu vaccination. Aim 4: To identify the molecular signatures of activated monocytes in response to Flu vaccination. RELEVANCE (See instructions): Despite the success of vaccines, we understand little about how effective ones stimulate protective immune responses. We will study how the flu vaccine generates effective antibody responses. The goal is to identify the immune responses elicited by effective vaccines so that vaccines that aren't as effective can be improved. To do this, we will vaccinate healthy people with the flu vaccine and monitor their immune response following the vaccination.   http://projectreporter.nih.gov/project_info_details.cfm?aid=8691692&icde=23828587&ddparam=&ddvalue=&ddsub=&cr=3&csb=default&cs=ASC"
            }
          ]
        }
      ]
    }
  ],
  
  "primaryPublications": [
    {
      "identifier":
        {
          "identifier": "N/A",
          "identifierSource": "pubmed"
        },
      "authorsList": "None",
      "title": "None",
      "publicationVenue": "None",
      "dates": [
        {
          "date": "None",
          "type": { "value": "publication year" }
        }
      ]
    }
  ],
  "types": [
      {
        "value": "Observational"
      },
      {
        "value": "Vaccine Response"
      }
  ],
  "dates": [
      {
          "date": "2010-11-01",
          "type": {
              "value": "actual_start_date"
          }
      },
      {
          "date": "2016-03-18",
          "type": {
              "value": "final_public_release_date"
          }
      }
  ],
  "availability": "Available for download after registration with ImmPort",
  "refinement": "Curated",
  "dimensions": [{
        "name": {
            "value": "Molecular Activity"
        },
        "description": "None",
        "types": [
            {
               "value": "Array"
            }
        ]
      }
      
  ],
  "isAbout": [
        {
          "name": "HIPC_PSOR_PPP-NONE"
        }
  ],
  "distributions": [
      {
          "identifier": {
              "identifier": "SDY667",
              "identifierSource": "ImmPort"
          },
          "title": "The immune signature of palmoplantar pustulosis",
          "access": {
              "landingPage": "http://www.immport.org",
              "accessURL": "http://www.immport.org/immport-open/public/study/study/displayStudyDetail/SDY667",
              "types": [
                  {
                      "value": "Download tab separated files"
                  },
                  {
                      "value": "Download MySQL files and schema"
                  }
              ],
              "authorizations": [
                {
                    "value": "Registraton with ImmPort required"
                }
              ]
          },
          "storedIn": {
              "name": "ImmPort",
              "types": [
                {
                  "value": "primary repository"
                }
              ]
         },
         "licenses": [
           {
             "name": "ImmPort User Agreement",
             "version": "1.0",
             "extraProperties": [
               {
                 "category": "Link to User Agreement",
                 "values": [
                   {
                     "value": "http://www.immport.org/agreement"
                   }
                 ]
               }
             ]
           }
         ]
      }
  ],
  "acknowledges": [
    {
      "identifier": {
        "identifier": ""
      },
      "name": "Systems Analysis Vaccine Responses in Healthy and Hyporesponsive Humans",
      "extraProperties": [
        {
          "category": "Link",
          "values": [
            {
              "value": "http://projectreporter.nih.gov/project_info_details.cfm?aid=8259851&icde=23826717&ddparam=&ddvalue=&ddsub=&cr=1&csb=default&cs=ASC"
            }
          ]
        }
      ]}
  ],
  "licenses": [
    {
      "name": "ImmPort User Agreement",
      "version": "1.0",
      "extraProperties": [
        {
          "category": "Link to User Agreement",
          "values": [
            {
              "value": "http://www.immport.org/agreement"
            }
          ]
        }
      ]
    }
  ],
  "description": "This study will compare adult patients with CPP(chronic plaque type psoriasis ), who are currently not undergoing topical, systemic or biologic treatment and matched healthy controls. Baseline demographics and psoriasis history will be recorded. All PPP patients will be comprehensively phenotyped and psoriasis severity assessed including the body surface area (BSA) involved, Psoriasis Area and Severity Index (PASI), Physicians Global assessment (PGA) and Dermatology Life Quality Index (DLQI)."
}
